CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma
Crossref DOI link: https://doi.org/10.1007/s00262-014-1598-8
Published Online: 2014-08-21
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
James, Britnie R.
Anderson, Kristin G.
Brincks, Erik L.
Kucaba, Tamara A.
Norian, Lyse A.
Masopust, David
Griffith, Thomas S.
Text and Data Mining valid from 2014-08-21